Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bernard Bégaud

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Geographic Areas

France

Concepts & Ideas

Chemicals & Drugs

Occupations

Pharmacoepidemiology

Activities & Behaviors

Procedures

Drug Information Services

Disorders

Substance-Related Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Baumevieille Marie; Daveluy Amélie; Maurain Catherine; Bégaud Bernard; Haramburu Françoise
Medicines submitted to narcotics regulations in France, 1992-2007.
Ahmed Ismaïl; Haramburu Françoise; Fourrier-Réglat Annie; Thiessard Frantz; Kreft-Jais Carmen; Miremont-Salamé Ghada; Bégaud Bernard; Tubert-Bitter Pascale
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
Lagnaoui Rajaa; Tournier Marie; Moride Yola; Wolfson Christina; Ducruet Thierry; Bégaud Bernard; Moore Nicholas
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bernard Bégaud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Baumevieille Marie; Daveluy Amélie; Maurain Catherine; Bégaud Bernard; Haramburu Françoise
Medicines submitted to narcotics regulations in France, 1992-2007.
Fundamental & clinical pharmacology 2009;23(3):345-9.
2009: Ahmed Ismaïl; Haramburu Françoise; Fourrier-Réglat Annie; Thiessard Frantz; Kreft-Jais Carmen; Miremont-Salamé Ghada; Bégaud Bernard; Tubert-Bitter Pascale
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
Statistics in medicine 2009;28(13):1774-92.
2009: Lagnaoui Rajaa; Tournier Marie; Moride Yola; Wolfson Christina; Ducruet Thierry; Bégaud Bernard; Moore Nicholas
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use.
Age and ageing 2009;38(2):226-8.
2009: Rossignol Michel; Abouelfath Abdelilah; Lassalle Regis; Merlière Yvon; Droz Cécile; Bégaud Bernard; Depont Fanny; Moride Yola; Blin Patrick; Moore Nicholas; Fourrier-Réglat Annie
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.
British journal of clinical pharmacology 2009;67(1):118-24.
2008: Grolleau A; Cougnard A; Bégaud B; Verdoux H
[Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey]
L'Encéphale 2008;34(4):352-9.
2008: Grégoire Fleur; Pariente Antoine; Fourrier-Reglat Annie; Haramburu Françoise; Bégaud Bernard; Moore Nicholas
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.
British journal of clinical pharmacology 2008;66(1):142-5.
2008: Fourrier-Réglat Annie; Droz-Perroteau Cécile; Bénichou Jacques; Depont Fanny; Amouretti Michel; Bégaud Bernard; Moride Yola; Blin Patrick; Moore Nicholas;
Impact of prescriber nonresponse on patient representativeness.
Epidemiology (Cambridge, Mass.) 2008;19(2):186-90.
2008: Grolleau A; Cougnard A; Bégaud B; Verdoux H
Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population.
Acta psychiatrica Scandinavica 2008;117(1):20-7.
2007: Grenouillet-Delacre Marieke; Verdoux Hélène; Moore Nicholas; Haramburu Françoise; Miremont-Salamé Ghada; Etienne Gabriel; Robinson Philip; Gruson Didier; Hilbert Gilles; Gabinski Claude; Bégaud Bernard; Molimard Mathieu
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.
Intensive care medicine 2007;33(12):2150-7.
2007: Arimone Yannick; Miremont-Salamé Ghada; Haramburu Françoise; Molimard Mathieu; Moore Nicholas; Fourrier-Réglat Annie; Bégaud Bernard
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
British journal of clinical pharmacology 2007;64(4):482-8.
2007: Martin-Latry Karin; Goumy Marie-Pierre; Latry Philippe; Gabinski Claude; Bégaud Bernard; Faure Isabelle; Verdoux Hélène
Psychotropic drugs use and risk of heat-related hospitalisation.
European psychiatry : the journal of the Association of European Psychiatrists 2007;22(6):335-8.
2007: Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Velo G P; Sturkenboom M; Blin P; Moore N;
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Pharmacoepidemiology and drug safety 2007;16(8):891-900.
2007: Tournier Marie; Molimard Mathieu; Titier Karine; Cougnard Audrey; Bégaud Bernard; Gbikpi-Benissan Georges; Verdoux Hélène
Accuracy of information on substance use recorded in medical charts of patients with intentional drug overdose.
Psychiatry research 2007;152(1):73-9.
2007: Bégaud Bernard
[A homage to Professeur Paul Montrastruc]
Thérapie 2007;62(3):275-6.
2007: Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Blin P; Moore N;
The CADEUS study: methods and logistics.
Pharmacoepidemiology and drug safety 2007;16(5):571-80.
2007: Martin K; Latry P; Moride Y; Bégaud B
[Where can we find French data for pharmacoepidemiology? A few thoughts]
Revue d'épidémiologie et de santé publique 2007;55(1):58-63.
2007: Baumevieille Marie; Bégaud Bernard; Maurain Catherine
[Charter of medicines promotion and rational use by physicians]
Thérapie 2007;62(1):39-44.
2006: Lagnaoui Rajaa; Baumevielle Marie; Bégaud Bernard; Pouyanne Pierre; Maurice Gwenaëlle; Depont Fanny; Moore Nicholas
Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France.
Thérapie 2006;61(4):341-6.
2006: Arimone Yannick; Bégaud Bernard; Miremont-Salamé Ghada; Fourrier-Réglat Annie; Molimard Mathieu; Moore Nicholas; Haramburu Françoise
A new method for assessing drug causation provided agreement with experts' judgment.
Journal of clinical epidemiology 2006;59(3):308-14.
2006: Verdoux Hélène; Tournier Marie; Cougnard Audrey; Martin Karin; Bégaud Bernard
[Pharmacoepidemiology of psychotropic medication: utilisation and impact in real-life conditions]
Thérapie 2006;61(1):17-22.
2005: Bruckert Eric; Hayem Gilles; Dejager Sylvie; Yau Caroline; Bégaud Bernard
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(6):403-14.
2005: Roux Emmanuel; Thiessard Frantz; Fourrier Annie; Bégaud Bernard; Tubert-Bitter Pascale
Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance.
IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society 2005;9(4):518-27.
2005: Verdoux Hélène; Cougnard Audrey; Grolleau Sabrina; Bégaud Bernard
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.
Schizophrenia research 2005;77(1):107-9.
2005: Arimone Yannick; Bégaud Bernard; Miremont-Salamé Ghada; Fourrier-Réglat Annie; Moore Nicholas; Molimard Mathieu; Haramburu Françoise
Agreement of expert judgment in causality assessment of adverse drug reactions.
European journal of clinical pharmacology 2005;61(3):169-73.
2005: Apretna Edwige; Haramburu Françoise; Taboulet Florence; Bégaud Bernard
[Medical and socio-economical impact of drug-induced adverse reactions]
Presse médicale (Paris, France : 1983) 2005;34(4):271-6.
2005: Ricard C; Martin K; Tournier M; Bégaud B; Verdoux H
[A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder]
L'Encéphale 2005;31(1 Pt 1):98-101.
2005: Daurel-Receveur Mathilde; Miremont-Salamé Ghada; Fourrier Annie; Auriche Pascal; Moore Nicholas; Bégaud Bernard; Haramburu Françoise;
[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France]
Thérapie 2005;60(1):61-5.
2005: Fourrier-Réglat Annie; de Bailliencourt Ségolène; Molimard Mathieu; Latry Philippe; Moore Nicholas; Peter Claude; Bégaud Bernard
[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France]
Thérapie 2005;60(1):25-9.
2005: Vray Muriel; Joubert Jean-Michel; Eschwège Eveline; Liard François; Fagnani Francis; Montestruc François; Fages Sophie; Bégaud Bernard
[Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat]
Thérapie 2005;60(1):17-24.
2005: Martin Karin; Moride Yola; Metge Colleen; Moore Nicholas; Bégaud Bernard
Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis.
The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2005;31(1):37-9.
2005: Thiessard Frantz; Roux Emmanuel; Miremont-Salamé Ghada; Fourrier-Réglat Annie; Haramburu Françoise; Tubert-Bitter Pascale; Bégaud Bernard
Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
Drug safety : an international journal of medical toxicology and drug experience 2005;28(8):731-40.
2005: Bégaud Bernard; Martin Karin; Abouelfath Abdelilah; Tubert-Bitter Pascale; Moore Nicholas; Moride Yola
An easy to use method to approximate Poisson confidence limits.
European journal of epidemiology 2005;20(3):213-6.
2005: Titier Karine; Girodet Pierre-Olivier; Verdoux Hélène; Molimard Mathieu; Bégaud Bernard; Haverkamp Wilhelm; Lader Malcolm; Moore Nicholas
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(1):35-51.
2005: Umar Anwar; Depont Fanny; Jacquet Alain; Lignot Severine; Segur Marie Claude; Boisseau Michel; Bégaud Bernard; Moore Nicholas
Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial.
Thrombosis research 2005;115(1-2):31-7.
2004: Bégaud Bernard; Verdoux Hélène
Did the US boycott of French products spread to include scientific output?
BMJ (Clinical research ed.) 2004;329(7480):1430-1.
2004: Vray Muriel; Joubert Jean-Michel; Eschwège Eveline; Liard François; Fagnani Francis; Commenges Bénédicte; Steinberg Ghislaine; Bégaud Bernard
[Methodology and quality control in EPIGRAM, a pharmacoepidemiological study of obesity in general practice]
Thérapie 2004;59(6):573-9.
2004: Umar Anwar; Boisseau Michel; Yusup Abdiryim; Upur Halmurat; Bégaud Bernard; Moore Nicholas
Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
Fundamental & clinical pharmacology 2004;18(5):559-63.
2004: Moore Nicholas; Diris Hélène; Martin Karin; Viale Raymond; Fourrier Annie; Moride Yola; Bégaud Bernard
NSAID use profiles derived from reimbursement data in France.
Thérapie 2004;59(5):541-6.
2004: Lagnaoui Rajaa; Depont Fanny; Fourrier Annie; Abouelfath Abdelillah; Bégaud Bernard; Verdoux Hélène; Moore Nicholas
Patterns and correlates of benzodiazepine use in the French general population.
European journal of clinical pharmacology 2004;60(7):523-9.
2004: Verdoux Hélène; Bégaud Bernard
Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?
The British journal of psychiatry : the journal of mental science 2004;185():93-4.
2004: Pradel Vincent; Thirion Xavier; Ronfle Eléonore; Masut Alain; Micallef Joëlle; Bégaud Bernard
Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database.
Pharmacoepidemiology and drug safety 2004;13(7):473-81.
2004: Matsika Marcelle-Diane; Tournier Marie; Lagnaoui Rajaa; Pehourcq Fabienne; Molimard Mathieu; Bégaud Bernard; Verdoux Hélène; Moore Nicholas
Comparison of patient questionnaires and plasma assays in intentional drug overdoses.
Basic & clinical pharmacology & toxicology 2004;95(1):31-7.
2004: Martin K; Bégaud B; Verdoux H; Lechevallier N; Latry P; Moore N
Patterns of risperidone prescription: a utilization study in south-west France.
Acta psychiatrica Scandinavica 2004;109(3):202-6.
2004: Martin Karin; Bégaud Bernard; Latry Philippe; Miremont-Salamé Ghada; Fourrier Annie; Moore Nicholas
Differences between clinical trials and postmarketing use.
British journal of clinical pharmacology 2004;57(1):86-92.
2004: Théophile Hélène; Bégaud Bernard; Martin Karin; Laporte Juan Ramon; Capella Dolores
Incidence of agranulocytosis in Southwest France.
European journal of epidemiology 2004;19(6):563-5.
2003: Tournier M; Molimard M; Abouelfath A; Cougnard A; Fourrier A; Haramburu F; Bégaud B; Verdoux H
Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patients.
Acta psychiatrica Scandinavica 2003;108(6):410-8.
2003: Bégaud Bernard; Fourrier Annie; Moore Nicholas; Moride Yola
The delusion of reducing sample size.
European journal of clinical pharmacology 2003;59(8-9):711-2.
2003: Lagnaoui Rajaa; Moore Nicholas; Moride Yola; Miremont-Salamé Ghada; Bégaud Bernard
Benzodiazepine utilization patterns in Alzheimer's disease patients.
Pharmacoepidemiology and drug safety 2003;12(6):511-5.
2003: Moore Nicholas; Tubert-Bitter Pascale; Fourrier Anne; Bégaud Bernard
A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.
Journal of clinical epidemiology 2003;56(5):433-5.
2003: Dangoumau Jacques; Haramburu Françoise; Bégaud Bernard
[Some questions about statins]
Thérapie 2003;58(1):91-5.
2002: Bégaud Bernard; Martin Karin; Fourrier Annie; Haramburu Françoise
Does age increase the risk of adverse drug reactions?
British journal of clinical pharmacology 2002;54(5):550-2.
2002: Bégaud Bernard; Bergman Ulf; Eichler Hans-Georg; Leufkens Hubert G M; Meier Peter J
Drug reimbursement: indicators of inappropriate resource allocation.
British journal of clinical pharmacology 2002;54(5):528-34.
2002: Bégaud Bernard
[Epidemiology of leg ulcers]
Annales de dermatologie et de vénéréologie 2002;129(10 Pt 2):1225-6.
2002: Bégaud Bernard; Martin Karin; Haramburu Françoise; Moore Nicholas
Rates of spontaneous reporting of adverse drug reactions in France.
JAMA : the journal of the American Medical Association 2002;288(13):1588.
2002: Touzé Emmanuel; Fourrier Annie; Rue-Fenouche Cécile; Rondé-Oustau Véronique; Jeantaud Isabelle; Bégaud Bernard; Alpérovitch Annick
Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.
Neuroepidemiology 2002;21(4):180-6.
2002: Lagnaoui Rajaa; Bégaud Bernard; Moore Nicholas; Chaslerie Anicet; Fourrier Annie; Letenneur Luc; Dartigues Jean François; Moride Yola
Benzodiazepine use and risk of dementia: a nested case-control study.
Journal of clinical epidemiology 2002;55(3):314-8.
2001: Lagnaoui R; Moore N; Longy-Boursier M; Baumevieille M; Bégaud B
Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.
Pharmacoepidemiology and drug safety 2001;10(6):531-5.
2001: Lagnaoui R; Moore N; Dartigues J F; Fourrier A; Bégaud B
Benzodiazepine use and wine consumption in the French elderly.
British journal of clinical pharmacology 2001;52(4):455-6.
2001: Fourrier A; Letenneur L; Dartigues J F; Moore N; Bégaud B
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.
European journal of clinical pharmacology 2001;57(5):419-25.
2001: Jeantaud I; Haramburu F; Bégaud B
[Benzodiazepine consumption: survey of community pharmacies in Aquitaine]
Thérapie 2001;56(4):415-9.
2001: Lacoste-Roussillon C; Pouyanne P; Haramburu F; Miremont G; Bégaud B
Incidence of serious adverse drug reactions in general practice: a prospective study.
Clinical pharmacology and therapeutics 2001;69(6):458-62.
2001: Moore N; Pierfitte C; Pehourcq F; Lagnaoui R; Bégaud B
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.
Clinical pharmacology and therapeutics 2001;69(6):445-50.
2001: Fourrier A; Bégaud B; Alpérovitch A; Verdier-Taillefer M H; Touzé E; Decker N; Imbs J L
Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.
British journal of clinical pharmacology 2001;51(5):489-90.
2001: Pierfitte C; Macouillard G; Thicoïpe M; Chaslerie A; Pehourcq F; Aïssou M; Martinez B; Lagnaoui R; Fourrier A; Bégaud B; Dangoumau J; Moore N
Benzodiazepines and hip fractures in elderly people: case-control study.
BMJ (Clinical research ed.) 2001;322(7288):704-8.
2001: Baumevieille M; Miremont G; Haramburu F; Maurain C; Bégaud B
[The French system of evaluation of dependence: establishment in a legal system]
Thérapie 2001;56(1):15-22.
2000: Tubert-Bitter P; Manfredi R; Lellouch J; Bégaud B
Sample size calculations for risk equivalence testing in pharmacoepidemiology.
Journal of clinical epidemiology 2000;53(12):1268-74.
2000: Pierfitte C; Royer R J; Moore N; Bégaud B
The link between sunshine and phototoxicity of sparfloxacin.
British journal of clinical pharmacology 2000;49(6):609-12.
2000: Lagnaoui R; Moore N; Fach J; Longy-Boursier M; Bégaud B
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.
European journal of clinical pharmacology 2000;56(2):181-6.
2000: Pouyanne P; Haramburu F; Imbs J L; Bégaud B
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.
BMJ (Clinical research ed.) 2000;320(7241):1036.
2000: Bégaud B; Dangoumau J
[Pharmacoepidemiology: definitions, problems, methodology]
Thérapie 2000;55(1):113-7.
2000: Haramburu F; Pouyanne P; Imbs J L; Blayac J P; Bégaud B
[Incidence and prevalence of adverse drug reactions]
Presse médicale (Paris, France : 1983) 2000;29(2):111-4.
2000: Fourrier A; Gasquet I; Allicar M P; Bouhassira M; Lépine J P; Bégaud B
Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists.
British journal of clinical pharmacology 2000;49(1):80-6.
1999: Abenhaim L; Moore N; Bégaud B
The role of pharmacoepidemiology in pharmacovigilance: a conference at the 6th ESOP Meeting, Budapest, 28 September 1998.
Pharmacoepidemiology and drug safety 1999;8 Suppl 1():S1-7.
1999: Lagnaoui R; Barcat D; Fach J; Bégaud B; Longy-Boursier M
[Dextropropoxyphene-paracetamol and general convulsive crisis: case report]
Thérapie 1999;54(2):262-3.
1999: Jeantaud I; Haramburu F; Bégaud B
[Substitution treatment for opiate dependence: survey of community pharmacies in Aquitaine]
Thérapie 1999;54(2):251-5.
1999: Pierfitte C; Bégaud B; Lagnaoui R; Moore N D
Is reporting rate a good predictor of risks associated with drugs?
British journal of clinical pharmacology 1999;47(3):329-31.
1999: Imbs J L; Pouyanne P; Haramburu F; Welsch M; Decker N; Blayac J P; Bégaud B
[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]
Thérapie 1999;54(1):21-7.
1997: Moore N; Kreft-Jais C; Haramburu F; Noblet C; Andrejak M; Ollagnier M; Bégaud B
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.
British journal of clinical pharmacology 1997;44(5):513-8.
1997: Haramburu F; Bégaud B; Moride Y
Temporal trends in spontaneous reporting of unlabelled adverse drug reactions.
British journal of clinical pharmacology 1997;44(3):299-301.
1997: Baumevieille M; Haramburu F; Bégaud B
Abuse of prescription medicines in southwestern France.
The Annals of pharmacotherapy 1997;31(7-8):847-50.
1997: Moride Y; Haramburu F; Requejo A A; Bégaud B
Under-reporting of adverse drug reactions in general practice.
British journal of clinical pharmacology 1997;43(2):177-81.
1996: Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
The New England journal of medicine 1996;335(9):609-16.
1994: Tubert-Bitter P; Bégaud B; Moride Y; Abenhaim L
Sample size calculations for single group post-marketing cohort studies.
Journal of clinical epidemiology 1994;47(4):435-9.
1994: Bégaud B; Chaslerie A; Haramburu F
[Organization and results of drug vigilance in France]
Revue d'épidémiologie et de santé publique 1994;42(5):416-23.
1994: Miremont G; Haramburu F; Bégaud B; Péré J C; Dangoumau J
Adverse drug reactions: physicians' opinions versus a causality assessment method.
European journal of clinical pharmacology 1994;46(4):285-9.
1993: Haramburu F; Abraham E; Bégaud B
[Users of a regional center of pharmacovigilance]
Thérapie 1993;48(5):475-7.
1993: Haramburu F; Miremont G; Chaslerie A; Bégaud B; Dangoumau J
Efficiency of medical journals for pharmacovigilance.
Lancet 1993;341(8851):1030-1.
1992: Tubert P; Bégaud B; Péré J C; Haramburu F; Lellouch J
Power and weakness of spontaneous reporting: a probabilistic approach.
Journal of clinical epidemiology 1992;45(3):283-6.
1991: Tubert P; Bégaud B; Haramburu F; Péré J C
Spontaneous reporting: how many cases are required to trigger a warning?
British journal of clinical pharmacology 1991;32(4):407-8.
1990: Péré J C; Haramburu F; Salamé G; Chaslerie A; Die-Kakou H; Pelletier A; Delmas N; Bégaud B
[Computerized data processing in the Pharmacovigilance Center of Bordeaux-Aquitaine. Analysis of clientele of the Center]
Thérapie 1990;45(5):391-7.
1990: Haramburu F; Bégaud B; Péré J C
Comparison of 500 spontaneous and 500 published reports of adverse drug reactions.
European journal of clinical pharmacology 1990;39(3):287-8.
1987: Péré J C; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
[Activities of a regional drug monitoring center. What to evaluate, how and for what purpose]
Thérapie 1987;42(4):351-8.
1987: Bégaud B; Péré J C; Tubert P; Barat C; Haramburu F; Albin H
[Information centers on undesirable effects of drugs: also on alerting function]
Thérapie 1987;42(2):231-7.
1987: Haramburu F; Bégaud B; Péré J C; Albin H
[Adverse effects of orphan drugs]
Thérapie 1987;42(1):63.
1987: Péré J C; Bégaud B; Haramburu F; Albin H
[Record linkage: a technic in drug surveillance]
Thérapie 1987;42(1):59-62.
1985: Péré J C; Godin M H; Bégaud B; Haramburu F; Albin H
[Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods]
Thérapie 1985;40(5):307-12.
1984: Péré J C; Bégaud B; Haramburu F; Albin H
[Methods for studying the adverse effects of drugs. II. Profile and comparison of 5 methods for establishing causality]
Thérapie 1984;39(4):369-78.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Bernard Bégaud

Research Profile (preview)

Geographic Areas

Concepts & Ideas

Chemicals & Drugs

Occupations

Activities & Behaviors

Procedures

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Bernard Bégaud (preview)

All Publications